Article Information
History
- September 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Sarah J. Tabrizi1,*,†,
- Scott Schobel2,*,
- Emily C. Gantman3,
- Alexandra Mansbach4,
- Beth Borowsky5,
- Pavlina Konstantinova6,
- Tiago A. Mestre7,
- Jennifer Panagoulias8,
- Christopher A. Ross9,
- Maurice Zauderer10,
- Ariana P. Mullin8,
- Klaus Romero11,
- Sudhir Sivakumaran11,
- Emily C. Turner11,
- Jeffrey D. Long12,
- Cristina Sampaio3,† and
- on behalf of the Huntington’s Disease Regulatory Science Consortium (HD-RSC)
- 1UCL Huntington’s Disease Centre, Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, UK Dementia Research Institute at UCL, WC1N 3BG, UK
- 2Product Development Neuroscience, F. Hoffmann-La Roche, Ltd, Grenzacherstrasse 124 Basel Switzerland 4070
- 3CHDI Management/CHDI Foundation Inc, Princeton, New Jersey 08540, USA
- 4APS Consulting Services Ltd., Washington, DC 20003, USA
- 5Novartis Pharmaceuticals, East Hanover, New Jersey 07936, USA
- 6VectorY BV, Science Park 408, 1098 XH Amsterdam, The Netherlands
- 7Parkinson’s Disease and Movement Disorders Centre, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario K1H 8M5, Canada
- 8Wave Life Sciences, Cambridge, Massachusetts 02138, USA
- 9Johns Hopkins University School of Medicine, Division of Neurobiology, Department of Psychiatry, and Departments of Neurology, Neuroscience and Pharmacology, Baltimore, Maryland 21287, USA
- 10Vaccinex, Inc., Rochester, New York 14620, USA
- 11Critical Path Institute, Tucson, Arizona 85718, USA
- 12Department of Psychiatry, Department of Biostatistics, University of Iowa, Iowa City, Iowa 52246, USA
- ↵†Corresponding authors:
Professor Sarah J Tabrizi, MD, FRCP, PhD, FMedSci., Director, Huntington’s Disease Centre, and Joint-Head, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology. Principal Investigator, UK Dementia Research Institute at University College London. s.tabrizi{at}ucl.ac.uk., Professor Cristina Sampaio MD, PhD, Chief Clinical Officer, CHDI Management/CHDI Foundation Inc, and Clinical Pharmacology Laboratory, Faculdade de Medicina de Lisboa, Portugal. Cristina.sampaio{at}chdifoundation.org.
Posted September 11, 2021.
Huntington’s Disease Integrated Staging System (HD-ISS): A Novel Evidence-Based Classification System For Staging
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos